Pediatrics
Guidelines
New JIA guidelines emphasize earlier DMARD use
Advances in understanding and treating systemic JIA have led practitioners away from steroids and toward using conventional synthetic and biologic...
Guidelines
New MIS-C guidance addresses diagnostic challenges, cardiac care
New updates in this third version of the American College of Rheumatology’s guidance include a recommendation for dual therapy with IVIg and...
Feature
Eighteen-year study shows inconsistencies in treating, classifying JIA
A long-term study of children with juvenile idiopathic arthritis highlights an inconsistent classification system and hints about how they manage...
News
FDA delays action on Pfizer vaccine for kids under 5
“At this time it makes sense for us to wait until we have the data of the evaluation of a third dose before taking action.”
Latest News
U.S. plans to roll out COVID-19 shots for children under 5 years in February
The drugmakers said they submitted data supporting authorization at the request of the FDA in order to address an urgent public health need in the...
Latest News
Agreement reached for research definition of ‘long COVID’ in children and young people
“Post–COVID-19 condition occurs in young people with a history of confirmed SARS CoV-2 infection, with at least one persisting physical symptom...
Conference Coverage
Absolute increase in Kawasaki CV risk remains small in long-term follow-up
Relative to controls, the increased long-term cardiovascular risk of patients with Kawasaki disease is small in most patients.
Latest News
Vaccines generally appear safe for kids on immune-modifying biologic therapy
Safety concerns essentially regard live vaccines, but multifactorial interactions may affect immunogenicity and efficacy for select vaccines.
Feature
COVID-vaccine myocarditis: Rare, mild, and usually in young men
Should myocarditis be a concern as mRNA-based COVID-19 vaccines are authorized in ever-younger age groups?
News
COVID-19 linked to increased diabetes risk in youth
Two large databases indicate significantly increased diabetes risk among those with COVID-19 but not other acute respiratory illnesses.
Latest News
EU regulator backs tocilizumab for treating severe COVID-19
The biologic tocilizumab was previously approved in June by the U.S. Food and Drug Administration for COVID-19 emergency use in hospital patients...